Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.37
(
0.02%
)
US TECH 100
29,122.20
(
-0.30%
)
Dow Jones
50,773.97
(
0.62%
)
Brent Oil
94.21
(
-2.87%
)
Bitcoin
74,851.55
(
-1.32%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ello post# 1519

Thursday, 03/18/2004 3:34:25 PM

Thursday, March 18, 2004 3:34:25 PM

Post# of 257644
I’ve looked at MZT (formerly NMPS) and EXAS from time to time, but I haven’t been too impressed with either.

Cancer diagnostics have to be really good to be useful for testing a general population. Otherwise, the number of false positives will overwhelm the number of cancers detected.

P.S. Being physically close to a company is not a good enough reason to invest. Pro-Pharmaceuticals is practically next door, but I’m glad I didn’t bite (#msg-2596707).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today